Kalshi Seeks Approval for Altcoin Perpetual Futures

Altcoin Derivatives Take Center Stage

Kalshi has applied to self-certify derivatives tied to 12 major altcoins, including XRP, Solana, and Dogecoin, following the CFTC's Bitcoin perps approval. The US derivatives exchange filed with the CFTC on Monday. The regulator indicated a case-by-case approach for perpetual futures.

The move comes as the CFTC signaled a shift in its stance on cryptocurrency derivatives, approving Bitcoin perpetual futures on Friday. Kalshi is seeking to capitalize on the emerging market. Perpetual futures are a type of derivative that allows traders to bet on the future price of an asset without an expiration date.

Will Altcoin Perpetual Futures Gain Traction?

Kalshi's application includes derivatives tied to prominent altcoins such as XRP, Solana, and Dogecoin. The exchange is also seeking to offer derivatives on other major altcoins. The CFTC's approval process will determine which of these derivatives will be allowed to trade.

The regulator's decision to approve Bitcoin perpetual futures on a case-by-case basis suggests that other cryptocurrency derivatives may be approved in the future. This could lead to increased liquidity and trading activity in the cryptocurrency derivatives market.

The approval of altcoin perpetual futures could have significant implications for the cryptocurrency market. It could provide traders with new opportunities to hedge against price volatility and speculate on the future price of altcoins.

Frequently Asked Questions

The consequences of Kalshi's application will depend on the CFTC's decision. If approved, altcoin perpetual futures could become a major product for the exchange. This could lead to increased competition in the cryptocurrency derivatives market.

What is a perpetual future? What altcoins is Kalshi seeking to offer derivatives on? Kalshi is seeking to offer derivatives on 12 major altcoins, including XRP, Solana, and Dogecoin. What is the CFTC's role in approving derivatives? The CFTC is responsible for reviewing and approving derivatives products, including those offered by Kalshi, to ensure they comply with regulatory requirements.